Teleflex (TFX) Stock Forecast, Price Target & Predictions
TFX Stock Forecast
Teleflex stock forecast is as follows: an average price target of $257.67 (represents a 42.69% upside from TFX’s last price of $180.58) and a rating consensus of 'Buy', based on 9 wall street analysts offering a 1-year stock forecast.
TFX Price Target
TFX Analyst Ratings
Buy
Teleflex Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Oct 31, 2024 | Patrick Wood | Morgan Stanley | $275.00 | $201.06 | 36.78% | 52.29% |
Oct 14, 2024 | Richard Newitter | Truist Financial | $255.00 | $237.10 | 7.55% | 41.21% |
Aug 05, 2024 | Richard Newitter | Truist Financial | $247.00 | $237.13 | 4.16% | 36.78% |
Aug 02, 2024 | Larry Biegelsen | Wells Fargo | $243.00 | $235.95 | 2.99% | 34.57% |
Jul 09, 2024 | Richard Newitter | Truist Financial | $235.00 | $211.73 | 10.99% | 30.14% |
Jul 01, 2024 | Matt O'Brien | Piper Sandler | $245.00 | $210.33 | 16.48% | 35.67% |
May 03, 2024 | Shagun Singh | RBC Capital | $255.00 | $198.73 | 28.31% | 41.21% |
May 02, 2024 | Matthew Taylor | Jefferies | $240.00 | $203.01 | 18.22% | 32.91% |
Jan 06, 2023 | Morgan Stanley | $280.00 | $257.54 | 8.72% | 55.06% | |
Dec 28, 2022 | Stephens | $295.00 | $249.12 | 18.42% | 63.36% | |
Dec 20, 2022 | Truist Financial | $272.00 | $241.63 | 12.57% | 50.63% | |
Apr 29, 2022 | Morgan Stanley | $343.00 | $290.20 | 18.19% | 89.94% | |
Apr 29, 2022 | Raymond James | $355.00 | $289.12 | 22.79% | 96.59% | |
Apr 29, 2022 | Needham | $355.00 | $295.50 | 20.14% | 96.59% | |
Dec 09, 2021 | Alyce Lomax | Motley Fool | $415.00 | $320.03 | 29.68% | 129.82% |
Jul 30, 2021 | Richard Newitter | Leerink Partners | $415.00 | $396.26 | 4.73% | 129.82% |
Teleflex Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | 1 | 8 |
Avg Price Target | - | $275.00 | $249.38 |
Last Closing Price | $180.58 | $180.58 | $180.58 |
Upside/Downside | -100.00% | 52.29% | 38.10% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Oct 31, 2024 | Morgan Stanley | Overweight | Overweight | Hold |
Oct 14, 2024 | Truist Financial | Hold | Hold | Hold |
Oct 14, 2024 | Stephens | Underperform | Underperform | Hold |
Oct 08, 2024 | RBC Capital | Outperform | Outperform | Hold |
Aug 02, 2024 | Wells Fargo | Equal-Weight | Equal-Weight | Hold |
Jul 01, 2024 | Piper Sandler | Neutral | Overweight | Upgrade |
May 03, 2024 | Truist Financial | Market Outperform | Market Outperform | Hold |
May 03, 2024 | RBC Capital | Outperform | Outperform | Hold |
May 02, 2024 | Jefferies | Hold | Hold | Hold |
Jan 12, 2024 | Truist Financial | Hold | Hold | Hold |
Dec 20, 2023 | Stephens | Hold | Hold | Hold |
Dec 04, 2023 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
Feb 24, 2023 | CFRA | Buy | Upgrade | |
Jan 06, 2023 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
Dec 28, 2022 | Stephens | Overweight | Overweight | Hold |
Aug 22, 2022 | Piper Sandler | Neutral | Neutral | Hold |
Jul 29, 2022 | Wells Fargo | Overweight | Downgrade | |
May 23, 2022 | RBC Capital | Outperform | Outperform | Hold |
Apr 29, 2022 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
Apr 29, 2022 | Raymond James | Outperform | Outperform | Hold |
Apr 29, 2022 | Needham | Buy | Buy | Hold |
Feb 25, 2022 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
Feb 23, 2022 | Raymond James | Outperform | Outperform | Hold |
Teleflex Financial Forecast
Teleflex Revenue Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $746.39M | $743.26M | $710.93M | $758.00M | $686.79M | $704.54M | $641.72M | $761.91M | $700.25M | $713.47M | $633.92M | $711.18M | $628.30M | $567.03M | $630.64M | $680.95M | $648.32M |
Avg Forecast | $890.79M | $839.65M | $836.44M | $807.53M | $854.22M | $802.06M | $796.09M | $768.67M | $813.31M | $768.68M | $762.98M | $727.54M | $768.72M | $733.56M | $729.87M | $686.83M | $760.35M | $691.53M | $719.52M | $631.89M | $749.61M | $698.20M | $685.80M | $621.03M | $687.67M | $619.33M | $537.91M | $617.73M | $679.01M | $643.20M |
High Forecast | $900.98M | $849.25M | $846.01M | $816.77M | $864.00M | $811.23M | $805.20M | $772.65M | $820.11M | $768.86M | $762.98M | $727.89M | $771.99M | $741.00M | $738.22M | $694.69M | $764.94M | $691.53M | $719.52M | $631.89M | $749.61M | $698.20M | $685.80M | $621.03M | $687.67M | $619.33M | $537.91M | $617.73M | $679.01M | $643.20M |
Low Forecast | $876.92M | $826.57M | $823.41M | $794.96M | $840.92M | $789.57M | $783.69M | $756.33M | $808.78M | $768.50M | $762.98M | $727.19M | $766.07M | $720.70M | $718.51M | $676.13M | $751.06M | $691.53M | $719.52M | $631.89M | $749.61M | $698.20M | $685.80M | $621.03M | $687.67M | $619.33M | $537.91M | $617.73M | $679.01M | $643.20M |
# Analysts | 5 | 4 | 8 | 5 | 3 | 3 | 6 | 9 | 11 | 5 | 7 | 10 | 14 | 13 | 6 | 6 | 5 | 5 | 5 | 11 | 12 | 11 | 10 | 9 | 9 | 6 | 4 | 4 | 7 | 4 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 1.02% | 1.04% | 1.00% | 0.99% | 0.98% | 1.02% | 1.02% | 1.00% | 1.04% | 1.02% | 1.03% | 1.01% | 1.05% | 1.02% | 1.00% | 1.01% |
Forecast
Teleflex EBITDA Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 5 | 4 | 8 | 5 | 3 | 3 | 6 | 9 | 11 | 5 | 7 | 10 | 14 | 13 | 6 | 6 | 5 | 5 | 5 | 11 | 12 | 11 | 10 | 9 | 9 | 6 | 4 | 4 | 7 | 4 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $137.67M | $111.42M | $177.87M | $146.27M | $183.04M | $192.03M | $164.08M | $214.59M | $299.69M | $176.25M | $163.53M | $152.09M | $189.17M | $96.33M | $213.42M | $173.14M | $170.79M |
Avg Forecast | $239.24M | $225.50M | $224.64M | $216.88M | $229.42M | $215.41M | $213.80M | $206.44M | $218.43M | $206.44M | $204.91M | $214.03M | $206.46M | $197.01M | $196.02M | $194.57M | $231.37M | $186.93M | $194.49M | $153.81M | $202.63M | $188.73M | $185.38M | $133.12M | $185.88M | $167.41M | $145.40M | $179.81M | $183.54M | $173.86M |
High Forecast | $241.97M | $228.08M | $227.21M | $219.36M | $232.04M | $217.87M | $216.25M | $207.51M | $220.26M | $206.49M | $204.91M | $256.84M | $207.33M | $199.01M | $198.26M | $233.49M | $277.64M | $186.93M | $194.49M | $184.58M | $202.63M | $188.73M | $185.38M | $159.74M | $185.88M | $167.41M | $145.40M | $215.78M | $183.54M | $173.86M |
Low Forecast | $235.51M | $221.99M | $221.14M | $213.50M | $225.85M | $212.05M | $210.48M | $203.13M | $217.21M | $206.40M | $204.91M | $171.23M | $205.74M | $193.56M | $192.97M | $155.66M | $185.09M | $186.93M | $194.49M | $123.05M | $202.63M | $188.73M | $185.38M | $106.50M | $185.88M | $167.41M | $145.40M | $143.85M | $183.54M | $173.86M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.70% | 0.57% | 0.91% | 0.63% | 0.98% | 0.99% | 1.07% | 1.06% | 1.59% | 0.95% | 1.23% | 0.82% | 1.13% | 0.66% | 1.19% | 0.94% | 0.98% |
Forecast
Teleflex Net Income Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 5 | 4 | 8 | 5 | 3 | 3 | 6 | 9 | 11 | 5 | 7 | 10 | 14 | 13 | 6 | 6 | 5 | 5 | 5 | 11 | 12 | 11 | 10 | 9 | 9 | 6 | 4 | 4 | 7 | 4 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $137.14M | $111.33M | $76.75M | $78.59M | $101.89M | $105.51M | $77.14M | $127.46M | $199.18M | $83.25M | $74.87M | $76.13M | $116.59M | $11.46M | $131.15M | $108.27M | $228.93M |
Avg Forecast | $211.92M | $194.43M | $191.14M | $180.96M | $194.87M | $179.18M | $174.56M | $165.31M | $181.61M | $159.48M | $156.62M | $102.27M | $153.46M | $153.70M | $150.79M | $92.97M | $138.09M | $147.50M | $158.27M | $73.49M | $167.26M | $143.34M | $136.00M | $60.94M | $144.38M | $105.99M | $59.44M | $110.50M | $152.30M | $130.07M |
High Forecast | $215.08M | $197.32M | $193.98M | $183.65M | $197.76M | $181.85M | $177.16M | $170.94M | $184.90M | $159.49M | $156.66M | $122.72M | $158.17M | $156.52M | $153.03M | $111.56M | $165.71M | $147.50M | $158.27M | $88.19M | $167.26M | $143.34M | $136.00M | $73.13M | $144.38M | $105.99M | $59.44M | $132.60M | $152.30M | $130.07M |
Low Forecast | $207.63M | $190.49M | $187.27M | $177.29M | $190.92M | $175.56M | $171.03M | $157.32M | $177.37M | $159.47M | $156.59M | $81.81M | $150.64M | $149.47M | $147.74M | $74.38M | $110.47M | $147.50M | $158.27M | $58.80M | $167.26M | $143.34M | $136.00M | $48.76M | $144.38M | $105.99M | $59.44M | $88.40M | $152.30M | $130.07M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.89% | 0.74% | 0.83% | 0.57% | 0.69% | 0.67% | 1.05% | 0.76% | 1.39% | 0.61% | 1.23% | 0.53% | 1.10% | 0.19% | 1.19% | 0.71% | 1.76% |
Forecast
Teleflex SG&A Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 5 | 4 | 8 | 5 | 3 | 3 | 6 | 9 | 11 | 5 | 7 | 10 | 14 | 13 | 6 | 6 | 5 | 5 | 5 | 11 | 12 | 11 | 10 | 9 | 9 | 6 | 4 | 4 | 7 | 4 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $213.19M | $223.31M | $232.72M | $233.38M | $209.62M | $216.82M | $203.93M | $227.58M | $205.19M | $224.16M | $203.15M | $232.91M | $171.67M | $191.19M | $147.80M | $240.60M | $229.90M |
Avg Forecast | $285.39M | $269.00M | $267.97M | $258.71M | $273.67M | $256.96M | $255.05M | $246.26M | $260.56M | $246.27M | $244.44M | $270.36M | $246.28M | $235.01M | $233.83M | $245.78M | $245.38M | $218.70M | $227.55M | $194.29M | $237.07M | $220.81M | $216.89M | $165.37M | $217.48M | $195.87M | $170.12M | $124.53M | $214.74M | $203.42M |
High Forecast | $288.65M | $272.08M | $271.04M | $261.67M | $276.80M | $259.90M | $257.96M | $247.54M | $262.74M | $246.32M | $244.44M | $324.43M | $247.32M | $237.40M | $236.51M | $294.93M | $294.45M | $218.70M | $227.55M | $233.15M | $237.07M | $220.81M | $216.89M | $198.45M | $217.48M | $195.87M | $170.12M | $149.43M | $214.74M | $203.42M |
Low Forecast | $280.94M | $264.81M | $263.80M | $254.68M | $269.41M | $252.96M | $251.08M | $242.31M | $259.11M | $246.21M | $244.44M | $216.29M | $245.43M | $230.89M | $230.19M | $196.62M | $196.30M | $218.70M | $227.55M | $155.43M | $237.07M | $220.81M | $216.89M | $132.30M | $217.48M | $195.87M | $170.12M | $99.62M | $214.74M | $203.42M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.91% | 0.95% | 0.95% | 0.95% | 0.96% | 0.95% | 1.05% | 0.96% | 0.93% | 1.03% | 1.23% | 1.07% | 0.88% | 1.12% | 1.19% | 1.12% | 1.13% |
Forecast
Teleflex EPS Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 5 | 4 | 8 | 5 | 3 | 3 | 6 | 9 | 11 | 5 | 7 | 10 | 14 | 13 | 6 | 6 | 5 | 5 | 5 | 11 | 12 | 11 | 10 | 9 | 9 | 6 | 4 | 4 | 7 | 4 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $2.92 | $2.37 | $1.63 | $1.68 | $2.17 | $2.25 | $1.65 | $2.72 | $4.26 | $1.78 | $1.60 | $1.63 | $2.51 | $0.25 | $2.83 | $2.34 | $4.95 |
Avg Forecast | $4.51 | $4.14 | $4.07 | $3.85 | $4.15 | $3.81 | $3.71 | $3.52 | $3.86 | $3.39 | $3.33 | $3.08 | $3.26 | $3.27 | $3.21 | $2.97 | $3.44 | $3.11 | $3.34 | $2.72 | $3.53 | $3.03 | $2.87 | $2.42 | $3.05 | $2.24 | $1.25 | $2.33 | $3.22 | $2.75 |
High Forecast | $4.57 | $4.20 | $4.13 | $3.91 | $4.21 | $3.87 | $3.77 | $3.64 | $3.93 | $3.39 | $3.33 | $3.08 | $3.36 | $3.33 | $3.26 | $3.01 | $3.47 | $3.11 | $3.34 | $2.72 | $3.53 | $3.03 | $2.87 | $2.42 | $3.05 | $2.24 | $1.25 | $2.33 | $3.22 | $2.75 |
Low Forecast | $4.42 | $4.05 | $3.98 | $3.77 | $4.06 | $3.73 | $3.64 | $3.35 | $3.77 | $3.39 | $3.33 | $3.07 | $3.20 | $3.18 | $3.14 | $2.91 | $3.39 | $3.11 | $3.34 | $2.72 | $3.53 | $3.03 | $2.87 | $2.42 | $3.05 | $2.24 | $1.25 | $2.33 | $3.22 | $2.75 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.89% | 0.74% | 0.55% | 0.49% | 0.70% | 0.67% | 0.61% | 0.77% | 1.41% | 0.62% | 0.66% | 0.53% | 1.12% | 0.20% | 1.22% | 0.73% | 1.80% |
Forecast
Teleflex Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
COO | Cooper Companies | $98.00 | $250.86 | 155.98% | Buy |
HAE | Haemonetics | $68.29 | $107.00 | 56.68% | Buy |
TFX | Teleflex | $180.58 | $257.67 | 42.69% | Buy |
ATR | AptarGroup | $157.11 | $200.00 | 27.30% | Buy |
HOLX | Hologic | $71.41 | $87.33 | 22.29% | Buy |
ALC | Alcon | $91.38 | $107.80 | 17.97% | Buy |
WST | West Pharmaceutical Services | $339.57 | $393.00 | 15.73% | Buy |
ICUI | ICU Medical | $168.30 | $190.50 | 13.19% | Buy |
BDX | Becton, Dickinson and | $246.90 | $278.75 | 12.90% | Buy |
ANGO | AngioDynamics | $12.46 | $13.00 | 4.33% | Buy |
MMSI | Merit Medical Systems | $108.48 | $105.60 | -2.65% | Buy |
NVST | Envista | $21.37 | $20.29 | -5.05% | Hold |
RMD | ResMed | $252.86 | $233.50 | -7.66% | Hold |